Methods for monitoring cellular processing of .beta.-amyloid precursor protein

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5441870
SERIAL NO

07965971

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Processing of .beta.-amyloid precursor protein (.beta.APP) is monitored by detecting the secretion of a soluble .beta.APP fragment resulting from cleavage of .beta.APP at the amino-terminus of .beta.-amyloid peptide. In vivo monitoring of secretion of the .beta.APP fragment may be monitored for diagnosis and prognosis of Alzheimer's disease and other .beta.-amyloid-related diseases, while in vitro monitoring of such secretion from cultured cells may be monitored to identify inhibitors of .beta.-amyloid production. The .beta.APP fragment may be detected using antibodies and other specific binding substances which recognize a carboxy-terminal residue on the fragment.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ELAN PHARMACEUTICALS INC800 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fritz, Lawrence C San Francisco, CA 25 537
Schenk, Dale B Pacifica, CA 134 5655
Seubert, Peter A South San Francisco, CA 33 1397

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation